Home›Companies›Biotech & Pharma›Attralus

Attralus, Inc.

Updated Oct 27, 2026·Latest SEC filing Feb 9, 2024·Suggest an edit

About Attralus

Attralus is a private company based in Burlingame, California, incorporated in 2019 in Delaware. It has reported $172,774,820 raised in three offerings on Form D since December 2019. Its chief executive is Mark Timney.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jan 26, 2024Feb 9, 2024$55,999,931fully sold12$4.6MEquityRule 506(b)Form D ↗
Aug 31, 2021Sep 24, 2021$116,599,889fully sold22$5.2MEquityRule 506(b)Form D ↗
Dec 13, 2019Dec 27, 2019$175,000target not set5$35,000DebtRule 506(b)Form D ↗
Total, three offerings$172,774,820

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Attralus's Form D filed Feb 9, 2024.

MT
Mark Timney
Chief Executive Officer and Director
MK
Mehdi Khodadad
Executive officer
CG
GF
Glen Firestone
Executive officer
RK
Rahul Kakkar
Director
GB
Gregory Bell
Executive officer
SG
Spencer Guthrie
Executive officer
JT
James Testa
Executive officer
JB
Jake Bauer
Director
AD
Alex Denner
Director

Earlier filings also listed Jonathan Wall (executive officer, last listed Sep 2021) and Benson Fong (chief financial officer, last listed Sep 2021).

Sources

  1. SECAttralus, Inc. filing history